Development of a novel 3D tri-culture system in an in vitro non-small cell lung cancer (NSCLC) model

被引：0
|
作者：
Amann, Arno [1 ]
Zwierzina, Marit [1 ]
Huber, Julia M. [1 ]
Gamerith, Gabriele [1 ]
Bitsche, Mario [1 ]
Pechriggl, Elisabeth J. [1 ]
Hilbe, Wolfgang [1 ]
Zwierzina, Heinz [1 ]
机构：
[1] Med Univ Innsbruck, A-6020 Innsbruck, Austria
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2017
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Staging of non-small cell lung cancer (NSCLC): A review
    Tsim, S.
    O'Dowd, C. A.
    Milroy, R.
    Davidson, S.
    RESPIRATORY MEDICINE, 2010, 104 (12) : 1767 - 1774
  • [42] Sequential chemotherapy in non-small cell lung cancer (NSCLC)
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4831 - 4832
  • [43] Tumor hyaluronan (HA) as a novel biomarker in non-small cell lung cancer (NSCLC).
    Gong, Jun
    Guan, Michelle
    Galen, Cook-Wiens
    Larson, Brent K.
    Zhou, Jenny
    Patel, Rishi
    Lapite, Isaac
    Tuli, Richard
    Natale, Ronald B.
    Hendifar, Andrew Eugene
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] PET/MRI in Non-Small Cell Lung Cancer (NSCLC)
    Alorfi, Fawziah
    Bomanji, Jamshed
    Bertoletti, Linda
    Fraioli, Francesco
    SEMINARS IN NUCLEAR MEDICINE, 2025, 55 (02)
  • [45] Personalized Therapy of Non-small Cell Lung Cancer (NSCLC)
    Gadgeel, Shirish M.
    LUNG CANCER AND PERSONALIZED MEDICINE: NOVEL THERAPIES AND CLINICAL MANAGEMENT, 2016, 890 : 203 - 222
  • [46] Induction therapy for non-small cell lung cancer (NSCLC)
    Nakamura, H
    Furukawa, K
    Ikeda, N
    Shibuya, H
    Tanaka, K
    Okunaka, T
    Hirano, T
    Sakai, M
    Saito, M
    Konaka, C
    Kato, H
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 1029 - 1033
  • [47] A 3D tri-culture model of normal mammary gland. A tool for breast cancer initiation studies
    Nash, C. E.
    Holliday, D. L.
    Mavria, G.
    Tomlinson, D. C.
    Hanby, A. M.
    Speirs, V.
    CANCER RESEARCH, 2012, 72
  • [48] Docetaxel (Taxotere®):: Current clinical development in non-small cell lung cancer (NSCLC)
    Manegold, C
    MEDIZINISCHE KLINIK, 1998, 93 (09) : A16 - A21
  • [49] Therapeutic Interventional Mapping System (TIMS): A novel strategy for the selection of tri-targeted therapy combinations for non-small cell lung cancer (NSCLC).
    Mendelsohn, John
    Lazar, Vladimir
    Rubin, Eitan
    Pawitan, Yudi
    Bresson, Catherine
    Soria, Jean-Charles
    Eggermont, Alexander
    Wunder, Fanny
    Scoazec, Jean-Yves
    Hong, Waun Ki
    Blay, Jean-Yves
    Schilsky, Richard L.
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Novel agents in development for advanced non-small cell lung cancer
    Stinchcombe, Thomas E.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (05) : 240 - 253
12345